Tscan Therapeutics Inc is a biotechnology company focused on developing innovative therapies for cancer and other serious diseases through the intersection of immunotherapy and genomics
The company utilizes its proprietary technology platform to identify and harness T cell receptors that can specifically target tumor antigens, enabling the creation of personalized T cell therapies. By leveraging its expertise in T cell biology and advanced genomics, Tscan aims to improve patient outcomes and deliver more effective treatment options for various forms of cancer, with the goal of transforming the landscape of cancer therapy.
The Dow Jones closed higher by around 10 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.
Gainers QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.
